• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

    5/3/24 5:57:39 AM ET
    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Computer Manufacturing
    Technology
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AAPL alert in real time by email

    Shares of Apple Inc. (NASDAQ:AAPL) rose sharply in today's pre-market trading after the company reported better reported better-than-expected results for its second quarter.

    The company announced a $110-billion stock buyback program and a one-penny-per-share increase in its quarterly dividend.

    Apple shares jumped 5.9% to $183.24 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Vaxxinity, Inc. (NASDAQ:VAXX) gained 45.8% to $0.1519 in pre-market trading after falling 9% on Thursday. Vaxxinity recently announced its intention to voluntarily delist and deregister its Class A common stock.
    • El Pollo Loco Holdings, Inc. (NASDAQ:LOCO) gained 23.1% to $10.59 in pre-market trading after the company reported better-than-expected first-quarter results.
    • AXT, Inc. (NASDAQ:AXTI) rose 23.8% to $3.75 in today's pre-market trading after the company reported better-than-expected first-quarter financial results.
    • Jaguar Health, Inc. (NASDAQ:JAGX) jumped 20.7% to $0.3540 in pre-market trading after surging 30% on Thursday.
    • Ardelyx, Inc. (NASDAQ:ARDX) shares gained 19.2% to $8.09 in pre-market trading after the company reported better-than-expected first-quarter financial results.
    • OneSpan Inc. (NASDAQ:OSPN) shares gained 18.6% to $13.00 in pre-market trading after the company reported better-than-expected first-quarter adjusted EPS and sales.
    • Rapid Micro Biosystems Inc (NASDAQ:RPID) shares rose 16.2% to $1.15 in pre-market trading.
    • The OLB Group, Inc. (NASDAQ:OLB) shares gained 19.8% to $0.5636 in pre-market trading after gaining 12% on Thursday. The company announced its shareholders approve a 1-for-10 reverse split.
    • Amgen Inc. (NASDAQ:AMGN) shares rose 14.2% to $318.01 in pre-market trading after the company reported better-than-expected first-quarter financial results. Also, the company announced a $50 million milestone payment from Royalty Pharma.

    Losers

    • NanoVibronix, Inc. (NASDAQ:NAOV) fell 44.8% to $0.3988 in pre-market trading after gaining 7% on Thursday.
    • Sprout Social, Inc. (NASDAQ:SPT) shares declined 25.2% to $36.00 in pre-market trading after the company reported worse-than-expected first-quarter revenue results.
    • Marin Software Incorporated (NASDAQ:MRIN) fell 19.4% to $2.54 in pre-market trading after the company reported a year-over-year decrease on first-quarter revenue results.
    • Stem, Inc. (NYSE:STEM) shares fell 18.7% to $1.55 in pre-market trading after the company reported worse-than-expected first-quarter financial results and cut its FY24 revenue guidance.
    • Terran Orbital Corporation (NYSE:LLAP) shares fell 18.5% to $1.05 in pre-market trading fter Lockheed Martin withdrew its buyout proposal.
    • Cloudflare, Inc. (NYSE:NET) fell 14% to $76.50 pre-market trading after the company reported first-quarter financial results and issued FY24 revenue guidance below estimates.
    • Trupanion, Inc. (NASDAQ:TRUP) shares declined 13% to $20.68 in pre-market trading following first-quarter results.
    • BigBear.ai Holdings, Inc. (NYSE:BBAI) shares fell 12.1% to $1.52 in pre-market trading after the company reported worse-than-expected first-quarter financial results.
    • Expedia Group, Inc. (NASDAQ:EXPE) shares declined 10.1% to $121.92 in pre-market trading after the company lowered its full-year guidance.
    • Fortinet, Inc. (NASDAQ:FTNT) fell 8.3% to $59.81 pre-market trading after the company reported its first-quarter financial results.

    Now Read This: Investor Sentiment Increases Ahead Of Jobs Report, Dow Jumps Over 300 Points

    Get the next $AAPL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAPL
    $AMGN
    $ARDX
    $AXTI

    CompanyDatePrice TargetRatingAnalyst
    Amgen Inc.
    $AMGN
    3/10/2026$350.00Hold
    Jefferies
    El Pollo Loco Holdings Inc.
    $LOCO
    3/6/2026$11.00Neutral
    DA Davidson
    Apple Inc.
    $AAPL
    3/5/2026$267.00 → $268.00Neutral
    Rosenblatt
    Apple Inc.
    $AAPL
    3/3/2026$239.00 → $248.00Underweight
    Barclays
    Fortinet Inc.
    $FTNT
    3/3/2026$64.00Underweight
    Wells Fargo
    Sprout Social Inc
    $SPT
    2/27/2026$9.00Buy → Hold
    Canaccord Genuity
    Apple Inc.
    $AAPL
    2/25/2026$241.00 → $270.00Neutral
    MoffettNathanson
    Amgen Inc.
    $AMGN
    2/20/2026$185.00Equal Weight
    Barclays
    More analyst ratings

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REPATHA issued to AMGEN INC

    Submission status for AMGEN INC's drug REPATHA (SUPPL-44) with active ingredient EVOLOCUMAB has changed to 'Approval' on 11/20/2024. Application Category: BLA, Application Number: 125522, Application Classification:

    11/21/24 12:43:07 PM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    September 17, 2024 - FDA Roundup: September 17, 2024

    For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a

    9/17/24 2:34:22 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    September 12, 2024 - FDA Authorizes First Over-the-Counter Hearing Aid Software

    For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea

    9/12/24 10:58:17 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    SEC Filings

    View All

    SEC Form 144 filed by Stem Inc.

    144 - STEM, INC. (0001758766) (Subject)

    3/10/26 4:23:25 PM ET
    $STEM
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 144 filed by Stem Inc.

    144 - STEM, INC. (0001758766) (Subject)

    3/10/26 4:15:57 PM ET
    $STEM
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 144 filed by AXT Inc

    144 - AXT INC (0001051627) (Subject)

    3/10/26 3:28:41 PM ET
    $AXTI
    Semiconductors
    Technology

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Zenner Marc bought $34,782 worth of shares (3,300 units at $10.54), increasing direct ownership by 4% to 83,208 units (SEC Form 4)

    4 - OneSpan Inc. (0001044777) (Issuer)

    3/4/26 4:30:16 PM ET
    $OSPN
    EDP Services
    Technology

    Director Mott David M bought $1,946,331 worth of shares (333,333 units at $5.84), increasing direct ownership by 11% to 3,302,918 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 9:01:11 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Barretto Ryan Paul bought $1,002,621 worth of shares (93,984 units at $10.67), increasing direct ownership by 12% to 875,256 units (SEC Form 4)

    4 - Sprout Social, Inc. (0001517375) (Issuer)

    1/13/26 4:01:19 PM ET
    $SPT
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by AXT Inc

    4 - AXT INC (0001051627) (Issuer)

    3/10/26 7:21:53 PM ET
    $AXTI
    Semiconductors
    Technology

    SEC Form 4 filed by Stem Inc.

    4 - STEM, INC. (0001758766) (Issuer)

    3/10/26 5:12:58 PM ET
    $STEM
    Industrial Machinery/Components
    Miscellaneous

    President, Software Products Tappin Matthew converted options into 1,458 shares and sold $7,284 worth of shares (655 units at $11.12), increasing direct ownership by 33% to 3,225 units (SEC Form 4)

    4 - STEM, INC. (0001758766) (Issuer)

    3/10/26 5:13:14 PM ET
    $STEM
    Industrial Machinery/Components
    Miscellaneous

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies initiated coverage on Amgen with a new price target

    Jefferies initiated coverage of Amgen with a rating of Hold and set a new price target of $350.00

    3/10/26 8:40:05 AM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    DA Davidson initiated coverage on El Pollo Loco with a new price target

    DA Davidson initiated coverage of El Pollo Loco with a rating of Neutral and set a new price target of $11.00

    3/6/26 8:32:59 AM ET
    $LOCO
    Restaurants
    Consumer Discretionary

    Rosenblatt reiterated coverage on Apple with a new price target

    Rosenblatt reiterated coverage of Apple with a rating of Neutral and set a new price target of $268.00 from $267.00 previously

    3/5/26 8:07:39 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum

    LEXINGTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the KeyBanc Capital Markets Healthcare Forum. The Company is scheduled to participate in a virtual question and answer session with the host analyst on Tuesday, March 17, 2026, at 11:15 a.m. Eastern Time. A live webcast will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be a

    3/10/26 4:45:00 PM ET
    $RPID
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    The Credential Breach Epidemic Nobody Has Priced In

    VANCOUVER, British Columbia, March 10, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — Two out of every three breaches now trace back to stolen credentials, and attackers are reaching Active Directory in an average of just three hours after initial access, according to the Sophos 2026 Active Adversary Report[1]. The scale of the problem is driving capital into the space at speed: the global cybersecurity market is projected to grow from $248.28 billion in 2026 to $699.39 billion by 2034, a 13.8% CAGR driven by accelerating enterprise adoption of post-quantum and AI-powered defense platforms[2]. Companies building the security infrastructure for this environment include Quantu

    3/10/26 1:08:39 PM ET
    $CHKP
    $CRWD
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th

    NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place March 11–12, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here "We are delighted to highlight today's innovators from the Life Science

    3/10/26 10:21:44 AM ET
    $AEMD
    $CVKD
    $DYAI
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Biotechnology: Biological Products (No Diagnostic Substances)

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Leadership Updates

    Live Leadership Updates

    View All

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    El Pollo Loco Appoints Frank Garrido to Board of Directors

    COSTA MESA, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- El Pollo Loco (NASDAQ:LOCO), the nation's leading fire-grilled chicken restaurant, announced today the appointment of Frank Garrido as an independent member of its Board of Directors ("Board"), effective March 1, 2026. Mr. Garrido is Executive Vice President – Chief Restaurant Officer of Domino's Pizza, the largest pizza company in the world.  "I am thrilled to have Frank join our Board," said Liz Williams, CEO, El Pollo Loco. "We believe that his extensive restaurant operations experience will add significant value as we expand El Pollo Loco in our existing markets and across the country."  Mr. Garrido joined Domino's in 2017. In his

    1/28/26 9:00:00 AM ET
    $LOCO
    Restaurants
    Consumer Discretionary

    ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial

    TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldman as Vice President, Commercial. In this role, Mr. Waldman will lead ENvue's U.S. commercialization strategy, with a focus on expanding its existing presence in 38 hospitals and accelerating revenue across the Company's enteral platform. "Marc is a highly accomplished sales leader with extensive GPO and IDN expertise and long-standing relationships th

    1/21/26 8:30:00 AM ET
    $FEED
    $NAOV
    Industrial Specialties
    Health Care

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Financials

    Live finance-specific insights

    View All

    Stem Announces Fourth Quarter and Full Year 2025 Results

    Delivered Transformative 2025, Achieving First-Ever Full Year Positive Adjusted EBITDA Software-Centric Strategy Drives Revenue Growth, Record Margins, and Significant Cost Reductions Introducing 2026 Guidance, Targeting ~85% Adjusted EBITDA Growth and 10% ARR Expansion Fourth Quarter and Full Year 2025 Financial and Operating Highlights Financial Highlights – Full Year 2025 Revenue of $156.3 million, up 8% from $144.6 million for FY24 Software, services, and edge hardware revenue of $141.4 million, up 25% from $113.2 million for FY24 GAAP gross profit of $60.0 million, up from $(11.1) million for FY24 Non-GAAP gross profit of $72.3 million, up from $63.7 million for FY2

    3/4/26 4:05:00 PM ET
    $STEM
    Industrial Machinery/Components
    Miscellaneous

    AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND

    THOUSAND OAKS, Calif., March 4, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.52 per share dividend for the second quarter of 2026. The dividend will be paid on June 5, 2026, to all stockholders of record as of the close of business on May 15, 2026.About AmgenAmgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines. More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge

    3/4/26 4:01:00 PM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    OneSpan Completes Acquisition of Build38

    OneSpan Inc. (NASDAQ:OSPN) today announced that it has completed the acquisition of Build38, a leader in next-generation mobile application protection solutions. The signing of the definitive agreement was previously announced on January 12, 2026. With the transaction now closed, OneSpan officially brings Build38's advanced mobile security technology, engineering talent, and cloud-driven threat intelligence platform into its expanding cybersecurity portfolio. With Build38's technology now part of OneSpan, customers will gain access to expanded App Shielding capabilities through a more comprehensive and intelligence-driven approach to protecting their mobile applications, including the abi

    3/2/26 8:00:00 AM ET
    $OSPN
    EDP Services
    Technology

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/10/24 4:15:32 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology